封面
市場調查報告書
商品編碼
1517644

礦物質補充劑市場 - 按產品類型(鈣、鎂、鐵、鉀、鋅)、配方(膠囊和片劑、液體)、應用(一般健康、骨骼和關節健康)、消費者群體、配銷通路- 全球預測(2024 年 -第2032章

Mineral Supplements Market - By Product Type (Calcium, Magnesium, Iron, Potassium, Zinc), Formulation (Capsule & Tablets, Liquid), Application (General Health, Bone & Joint Health), Consumer Group, Distribution Channel - Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

礦物質補充劑市場規模預計 2024 年至 2032 年間複合年成長率為 4.7%。由於現代飲食和生活方式因素導致營養缺乏的風險,人們正在尋找補充劑來填補飲食中的空白。已開發國家的人口老化也推動了對骨骼健康和免疫系統抵抗力的礦物質補充劑的需求增加。根據世界衛生組織的數據,到 2030 年,全世界每 6 個人就有 6 人年齡超過 60 歲。

此外,運動員和運動者正在日常運動中添加礦物質補充劑,以最佳化表現、改善恢復並支持肌肉功能。由於運動員、健身影響者和健康專業人士的回饋,針對特定礦物質缺乏或表現目標的特殊配方的需求也有所增加。功能性飲料、蛋白質棒和其他方便的輸送形式的不斷轉變也使用戶更容易將礦物質補充劑納入他們的日常生活中。

本產業分為產品類型、配方、應用、消費群體、配銷通路和地區。

根據產品類型,鐵補充劑領域的礦物質補充劑市場預計將在2024 年至2032 年間出現顯著成長。鐵缺乏症並支持整體健康。配方技術的快速改進將促進該領域的成長,以獲得更好的鐵片。

到2032 年,骨骼和關節健康應用領域的礦物質補充劑市場價值將錄得顯著成長。水平。鈣、鎂和維生素 D 等礦物質補充劑因促進骨骼健康和關節功能而廣受歡迎。為了解決礦物質缺乏問題,骨質疏鬆症、關節炎和其他肌肉骨骼疾病的盛行率不斷上升,正在推動該領域的成長。

到 2032 年,亞太地區礦物質補充劑市場規模將呈現可觀成長。消費者正在認知到礦物質補充劑對健康的需求。醫療保健成本上升、零售擴張、政府對促進公共衛生和營養教育的支持以及礦物質補充劑採用率的增加將刺激該地區市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 營養缺乏症盛行率上升
      • 老年人口增加
      • 人們對健康和保健的認知不斷增強
      • 透過線上平台擴大可訪問性
    • 產業陷阱與挑戰
      • 嚴格的法規和不同的標準
      • 缺乏品質和誤導性聲明
  • 成長潛力分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按產品類型,2021 - 2032 年

  • 主要趨勢
  • 鈣補充劑
  • 鎂補充劑
  • 鐵補充劑
  • 鉀補充劑
  • 鋅補充劑
  • 鉻補充劑
  • 補硒
  • 其他補充劑

第 6 章:市場估計與預測:按配方分類,2021 - 2032 年

  • 主要趨勢
  • 膠囊和片劑
  • 液體
  • 粉末
  • 軟糖
  • 其他配方

第 7 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 整體健康
  • 骨骼和關節健康
  • 腸胃健康
  • 免疫支持
  • 其他應用

第 8 章:市場估計與預測:按消費者群體分類,2021 - 2032 年

  • 主要趨勢
  • 成年人
  • 孕婦
  • 孩子們

第 9 章:市場估計與預測:按配銷通路分類,2021 - 2032 年

  • 主要趨勢
  • 藥局和零售店
  • 超級市場和大賣場
  • 網上銷售
  • 其他分銷管道

第 10 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 11 章:公司簡介

  • Abbott Laboratories
  • Amway Corp.
  • Bayer AG
  • Bio Botanica, Inc.
  • BIOVEA
  • Catalent, Inc.
  • Dr. Paul Lohmann GmbH & Co. KGaA
  • Glanbia plc
  • Herbalife International of America, Inc.
  • Mineral Resources International, Inc.
  • Nestlé S.A.
  • NV Labs
  • Pfizer Inc.
  • Pharmavite
  • Sanofi
簡介目錄
Product Code: 9308

Mineral supplements market size is expected to witness 4.7% CAGR between 2024 and 2032. Consumer awareness of health importance is leading to the increased interest in dietary supplements. With risks of nutritional deficiencies due to modern diets and lifestyle factors, people are looking for supplements to fill the gaps in their diets. The aging population in developed countries is also driving the increased need for mineral supplements for bone health and immune system resistance. As per WHO, by 2030, every 6th person in the world will be over 60 years old.

Moreover, athletes and exercisers are adding mineral supplements to their routines to optimize performance, improve recovery and support muscle function. The demand for special formulations that target specific mineral deficiencies or performance goals has also increased due to the feedback from athletes, fitness influencers and health professionals. The rising shift towards functional beverages, protein bars, and other convenient delivery formats has also made it easier for users to incorporate mineral supplements into their daily routine.

The industry is classified into product type, formulation, application, consumer group, distribution channel and region.

Based on product type, the mineral supplements market from the iron supplements segment is slated to depict significant growth between 2024 to 2032. Of late, the demand for iron supplements to address deficiencies and support the overall health due to increased awareness of the consequences of iron deficiency is growing. The rapid improvements in formulation technology for better iron tablets will add to the segment growth.

Mineral supplements market value from the bone & joint health application segment will record significant growth rate through 2032. With the growing population, there is rising awareness regarding bone density and joint flexibility to support the overall mobility and standard of life. Mineral supplements like calcium, magnesium, and vitamin D are popular for promoting bone health and joint function. Rising prevalence of osteoporosis, arthritis, and other musculoskeletal conditions to address mineral deficiency is driving the segment growth.

Asia Pacific mineral supplements market size will exhibit decent growth through 2032. Rapid urbanization and changing eating habits have led to the increase in nutritional deficiencies, especially in developing economies. Consumers are recognizing the need for mineral supplements for health. Rising healthcare costs , retail expansion and government support for promoting public health and nutrition education as well as increasing mineral supplement adoption will stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of nutritional deficiencies
      • 3.2.1.2 Increasing elderly population
      • 3.2.1.3 Growing awareness for health and wellness
      • 3.2.1.4 Expanded accessibility by online platform
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulations and varying standards
      • 3.2.2.2 Lack of quality and misleading claims
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Calcium supplements
  • 5.3 Magnesium supplements
  • 5.4 Iron supplements
  • 5.5 Potassium supplements
  • 5.6 Zinc supplements
  • 5.7 Chromium supplements
  • 5.8 Selenium supplements
  • 5.9 Other supplements

Chapter 6 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Capsules & tablets
  • 6.3 Liquid
  • 6.4 Powder
  • 6.5 Gummies
  • 6.6 Other formulations

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 General health
  • 7.3 Bone & joint health
  • 7.4 Gastrointestinal health
  • 7.5 Immune support
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Consumer Group, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Adults
  • 8.3 Pregnant women
  • 8.4 Children

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pharmacies & retail stores
  • 9.3 Supermarkets & hypermarkets
  • 9.4 Online sales
  • 9.5 Other distribution channels

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 South Africa
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 Abbott Laboratories
  • 11.2 Amway Corp.
  • 11.3 Bayer AG
  • 11.4 Bio Botanica, Inc.
  • 11.5 BIOVEA
  • 11.6 Catalent, Inc.
  • 11.7 Dr. Paul Lohmann GmbH & Co. KGaA
  • 11.8 Glanbia plc
  • 11.9 Herbalife International of America, Inc.
  • 11.10 Mineral Resources International, Inc.
  • 11.11 Nestlé S.A.
  • 11.12 NV Labs
  • 11.13 Pfizer Inc.
  • 11.14 Pharmavite
  • 11.15 Sanofi